Freyer, C. W., Carulli, A., Gier, S., Ganetsky, A., Timlin, C., Schuster, M., Babushok, D., Frey, N. V., Gill, S. I., Hexner, E. O., Luger, S. M., Mangan, J. K., Martin, M. E., McCurdy, S. R., Perl, A. E., Porter, D. L., Pratz, K., Smith, J., Stadtmauer, E. A., & Loren, A. W. (2022). letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. Leukemia & lymphoma, 63(8), 1925–1933. http://access.bl.uk/ark:/81055/vdc_100166773025.0x000036